Clin Pain.  2022 Dec;21(2):74-79. 10.35827/cp.2022.21.2.74.

Digital Therapeutics for the Musculoskeletal Disorders

Affiliations
  • 1Department of Rehabilitation Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
  • 2Rehabilitation Institute of Neuromuscular Disease, Yonsei University College of Medicine, Seoul, Korea
  • 3Department of Integrative Medicine, Yonsei University College of Medicine, Seoul, Korea
  • 4Department of Medical Device Engineering and Management, Yonsei University College of Medicine, Seoul, Korea

Abstract

Digital therapeutics (DTx) is emerging in the field of digital healthcare thanks to the development of ICT (information and communications technology), sensors, and AI (artificial intelligence) technology. A clinical trial-based design and manufacturing process is required for DTx before it can be prescribed in the medical field. The risks, and effectiveness and intended use of DTx must then be approved by regulatory authorities. The digital healthcare apps for musculoskeletal disorders, which had previously concentrated on monitoring and feedback on aerobic exercise, have lately begun to be applied to rehabilitative exercises utilizing AI technologies using convolutional neural networks. The development of DTx focusing on therapeutic rehabilitative exercise is expected in the future.

Keyword

Digital therapeutics; Musculoskeletal disorders; Exercise
Full Text Links
  • CP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr